IRADIMED CORPORATION Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA

Stock Information for iRadimed Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About iRadimed Corporation

IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.